Rapid Micro Biosystems (RPID) Current Deferred Revenue (2020 - 2026)
Rapid Micro Biosystems (RPID) posted Current Deferred Revenue of $6.6 million for Q1 2026, up 39.42% sequentially from $4.7 million in Q4 2025, and up 8.34% YoY from $6.1 million in Q1 2025.
Rapid Micro Biosystems (RPID) Current Deferred Revenue (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has reported Current Deferred Revenue for 7 years, with the latest figure at $6.6 million in Q1 2026.
- Quarterly Current Deferred Revenue rose 8.34% year-over-year to $6.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.6 million (up 8.34% YoY) and the FY2025 annual result came in at $4.7 million, down 28.27% from the prior year.
- Current Deferred Revenue rose to $6.6 million in Q1 2026 per RPID's latest filing, from $4.7 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $6.6 million in Q4 2024 and troughed at $3.4 million in Q3 2022.
- A 5-year average of $5.2 million and a median of $5.4 million in 2024 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2022 and 2025: Current Deferred Revenue soared 42.39% in 2022, then retreated 28.27% in 2025.
- Over 5 years, Current Deferred Revenue stood at $4.7 million in 2022, then rose by 26.94% to $6.0 million in 2023, then rose by 10.48% to $6.6 million in 2024, then declined by 28.27% to $4.7 million in 2025, then jumped by 39.42% to $6.6 million in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $6.6 million, $4.7 million, and $5.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Rapid Micro Biosystems | 80.50 Mn | 60.73 Mn | 1.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.51 Mn |
| Mar 31, 2026 | 6.60 Mn |
| Dec 31, 2025 | 4.73 Mn |
| Sep 30, 2025 | 5.10 Mn |
| Jun 30, 2025 | 6.14 Mn |
| Mar 31, 2025 | 6.09 Mn |
| Dec 31, 2024 | 6.60 Mn |
| Sep 30, 2024 | 5.36 Mn |
| Jun 30, 2024 | 5.43 Mn |
| Mar 31, 2024 | 6.20 Mn |
| Dec 31, 2023 | 5.97 Mn |
| Sep 30, 2023 | 4.60 Mn |
| Jun 30, 2023 | 4.60 Mn |
| Mar 31, 2023 | 5.50 Mn |
| Dec 31, 2022 | 4.71 Mn |
| Sep 30, 2022 | 3.40 Mn |
| Jun 30, 2022 | 3.92 Mn |
| Mar 31, 2022 | 3.95 Mn |
| Dec 31, 2021 | 3.31 Mn |
| Sep 30, 2021 | 3.90 Mn |